Research Article
Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations
Table 1
Chemical structure and properties of MRI contrast agents in our series.
| | Trademark | Contrast medium | Molecular structure |
| | MultiHance 0.5 mol/L (Bracco, Milan, Italy) | Gd-BOPTA (gadobenate dimeglumine) | Linear, ionic | | Primovist 0.25 mol/L (Bayer Schering Pharma AG, Berlin, Germany) | Gd-EOB-DTPA (gadoxetic acid disodium) | Linear, ionic | | Dotarem 0.5 mol/L (Guerbet Research, Aulnay-sous-Bois, France) | Gd-DOTA (gadoterate meglumine) | Macrocyclic, ionic | | Gadovist 0.5 mol/L (Bayer Schering Pharma AG, Berlin, Germany) | Gd-BT-DO3A (gadobutrol) | Macrocyclic, nonionic | | Magnevist 0.5 mol/L (Bayer Schering Pharma AG, Berlin, Germany) | Gd-DTPA (gadopentetate dimeglumine) | Linear, ionic |
|
|
Note: Gadovist, Primovist, and Magnevist are from Bayer Healthcare, Berlin, Germany; Dotarem is from Guerbet, Villepinte, France.
|
